# TWOSTEP THERAPEUTICS, INC.: Developing a broadly applicable targeted peptide-drug conjugate for the treatment of solid tumors

**Lab Budget Score:** 70/100

| Field | Value |
|---|---|
| Organization | TWOSTEP THERAPEUTICS, INC. |
| Location | SAN CARLOS, CA |
| Project | Developing a broadly applicable targeted peptide-drug conjugate for the treatment of solid tumors |
| Project number | 1R44CA306597-01A1 |
| Mechanism | R44 |
| Institute | National Cancer Institute |
| Award | $1,303,289 |
| Awarded | 2026-09-04 |
| Project period | 2026-09-04 to 2028-08-31 |
| UEI | MHK8GE9N4NE7 |

## Why this score
- Award of $1M or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11390848). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.